CAR調:

Dengxiong Li1, Jie Wang2, Ruicheng Wu3

  • 1Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China.

PubMed
まとめ

腫瘍微環境 (TME) の代謝因子は,キメリック抗原受容体 (CAR) T細胞治療の有効性を阻害する. TMEの代謝をターゲットにすることで,CAR T細胞の機能を向上させ,がん治療の改善のために抵抗を克服することができます.

関連する概念動画

Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K